Outdoor Holding Co filed an exhibit document (EX-3.1 ex3-1.htm) with the SEC, which suggests the company is updating its corporate governance document...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
The company reported a second quarter 2026 loss from continuing operations and announced the sale of its Transit and Tolling businesses for $234 milli...
Park Dental Partners signed a definitive purchase agreement for a dental practice. The filing outlines transaction details but excludes material infor...
Applied Aerospace and Defense appointed Chris Rogers President and Chief Strategy Officer to support accelerated growth following its IPO. The appoint...
Institutional holdings report (13F-HR) filed by KTF INVESTMENTS, LLC....
Motorcar Parts of America reported Net Sales of $168.0M for Q3 FY2027, with guidance reaffirmed. The company expects strong growth driven by new busin...
Silence Therapeutics announced that divesiran met its primary efficacy endpoint in a Phase 2 trial for polycythemia vera, with high response rates and...
Institutional holdings report (13F-HR) filed by HORAN Wealth, LLC....
InTest reported strong Q2 2026 results with revenue of $35.3 million and adjusted EPS of $0.09, driven by Auto/EV demand, while revising previous Q1 f...
Institutional holdings report (13F-HR) filed by Crake Asset Management LLP....
Institutional holdings report (13F-HR) filed by Measured Wealth Private Client Group, LLC....
Replimune Group Inc. has entered into an underwriting agreement to sell an aggregate of 9,701,490 shares of common stock and pre-funded warrants for 2...
Phase 2 trial of ABCL635 met primary endpoints for hot flash reduction. The results mark a new efficacy benchmark for the treatment of vasomotor sympt...
Institutional holdings report (13F-HR) filed by Lightrock Netherlands B.V.....
Athene Holding Ltd. released its unaudited financial results for 2022, including detailed non-GAAP measures regarding net investment earnings, net flo...
Aeries Technology reported strong quarterly results with revenue rising 43% and profit and operating cash flow more than tripling. The company reaffir...
Institutional holdings report (13F-HR) filed by Munro Partners....
Sharplink reported Q2 2026 revenue increased to $11.5 million from $0.7 million, driven by its正式启动的ETH treasury strategy, supported by notable Ethereu...
Institutional holdings report (13F-HR) filed by Ironvine Capital Partners, LLC....
Jazz Pharmaceuticals announced a definitive agreement to acquire Actio Biosciences for $820 million upfront to acquire ABS-1230, a potential precision...